MARKET

WVE

WVE

WAVE LIFE SCIENC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.30
-0.17
-2.28%
Closed 16:58 10/29 EDT
OPEN
7.53
PREV CLOSE
7.47
HIGH
7.60
LOW
7.29
VOLUME
720.28K
TURNOVER
--
52 WEEK HIGH
39.98
52 WEEK LOW
6.61
MARKET CAP
321.68M
P/E (TTM)
-1.2890
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Benzinga's Top Upgrades, Downgrades For October 23, 2020
Upgrades * For Mattel Inc (NASDAQ: MAT), DA Davidson upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, Mattel showed an EPS of $0.95, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of 14.83 and a 52-week-low of 6.53. At the end of the
Benzinga · 6d ago
RBC Capital Initiates Coverage On WAVE Life Sciences with Sector Perform Rating, Announces Price Target of $13
RBC Capital initiates coverage on WAVE Life Sciences (NASDAQ:WVE) with a Sector Perform rating and announces Price Target of $13.
Benzinga · 10/23 10:29
Wave Life Sciences to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference
GlobeNewswire · 09/28 21:05
Mid-Afternoon Market Update: Dow Tumbles 400 Points; JinkoSolar Shares Jump
Toward the end of trading Wednesday, the Dow traded down 1.47% to 26887.20 while the NASDAQ fell 2.44% to 10,695.38. The S&P also fell, dropping 1.77% to 3,257.05.
Benzinga · 09/23 18:57
JKS, DQ, ACB and LAC among midday movers
Gainers: JinkoSolar Holding (JKS) +18%.HireQuest (HQI) +16%.American Well (AMWL) +16%.Hilltop Holdings (HTH) +13%.Daqo New Energy (DQ) +12%.Perion Network (PERI) +12%.Qutoutiao (QTT) +11%.Entercom Communications (ETM) +10%.Aerpio Pharmaceuticals (ARPO) +9%.Annexon (ANNX) +8%.Losers: AC Immune SA (ACIU) -43%.Wave
Seekingalpha · 09/23 16:39
Mid-Day Market Update: Gold Falls 2%; SPI Energy Shares Spike Higher
Midway through trading Wednesday, the Dow traded down 0.33% to 27197.66 while the NASDAQ fell 1.21% to 10,831.45. The S&P also fell, dropping 0.75% to 3,290.81.
Benzinga · 09/23 16:20
Unusual Options Activity Insight: WAVE Life Sciences
Shares of WAVE Life Sciences (NASDAQ: WVE) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $11.16. * Sentiment: BEARISH * Option Type: SWEEP * Trade Type: CALL * Expiration Date: 2020-10-16 * Strike Price: $20.00 * Volume: 295 *
Benzinga · 09/23 15:02
American Well, MediciNova among major healthcare gainers, AC Immune, Wave Life Sciences leads losers' pack
Gainers: American Well (AMWL) +17%, MediciNova (MNOV) +13%, Mallinckrodt (MNK) +7%, Capricor Therapeutics (CAPR) +8%, Adamas Pharmaceuticals (ADMS) +6%.Losers: AC Immune (ACIU) -42%, Wave Life Sciences (WVE) -34%, Rockwell Medical (RMTI) -28%, Aurora Cannabis (ACB) -23%, NanoVibronix NAOV -15%.
Seekingalpha · 09/23 14:56
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of WVE. Analyze the recent business situations of WAVE LIFE SCIENC through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average WVE stock price target is 17.13 with a high estimate of 27.00 and a low estimate of 8.00.
EPS
Institutional Holdings
Institutions: 143
Institutional Holdings: 47.59M
% Owned: 108.00%
Shares Outstanding: 44.07M
TypeInstitutionsShares
Increased
28
3.22M
New
31
1.92M
Decreased
24
5.74M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.04%
Pharmaceuticals & Medical Research
+0.17%
Key Executives
Chairman/Independent Director
Christian Henry
President/Chief Executive Officer/Director
Paul Bolno
Chief Financial Officer
David Gaiero
Senior Vice President
Christopher Francis
Senior Vice President
Kenneth Rhodes
Senior Vice President
Chandra Vargeese
Other
Michael Panzara
Director
Gregory Verdine
Independent Director
Mark Corrigan
Independent Director
Peter Kolchinsky
Independent Director
Koji Miura
Independent Director
Amy Pott
Independent Director
Adrian Rawcliffe
Independent Director
Ken Takanashi
Independent Director
Heidi Wagner
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About WVE
WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Wave Life Sciences Ltd stock information, including NASDAQ:WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.